1477
COM:OCUMENSION
Ocumension Therapeutics
- Stock
Last Close
5.19
25/11 08:08
Market Cap
4.65B
Beta: -
Volume Today
1.48M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 129.50K - | 1.64M 1,168.73% | 4.01M 144.07% | 14.55M 262.81% | 28.29M 94.44% | ||
average payables | 1.98M - | 6.64M 236.02% | 6.88M 3.52% | 13.05M 89.89% | 23.45M 79.61% | ||
average receivables | 69.36M - | 118.23M 70.47% | |||||
book value per share | -1.43 - | -3.60 151.92% | 8.28 330.17% | 5.12 38.14% | 4.35 15.12% | 4.54 4.39% | |
capex per share | -0.00 - | -0.00 175.54% | -1.01 75,559.41% | -1.09 8.69% | -0.49 55.24% | ||
capex to depreciation | -4.34 - | -0.63 85.40% | -65.48 10,226.22% | -47.83 26.95% | -7.66 83.98% | ||
capex to operating cash flow | 0.01 - | 0.01 10.51% | 1.43 20,120.01% | 3.38 135.68% | 1.54 54.25% | ||
capex to revenue | -4.03 - | -23.26 476.94% | -11.84 49.09% | -1.95 83.53% | |||
cash per share | 0.16 - | 2.17 1,258.21% | 6.73 210.10% | 2.91 56.79% | 2.04 29.94% | 1.64 19.63% | |
days of inventory on hand | 9.45K - | 640.87 93.22% | 94.86 85.20% | 156.99 65.49% | 116.20 25.98% | ||
days payables outstanding | 143.81K - | 1.98K 98.62% | 83.73 95.77% | 141.35 68.82% | 90.15 36.23% | ||
days sales outstanding | 318.51 - | 144.82 54.53% | |||||
debt to assets | 0.01 - | 0.00 91.80% | 0.00 185.14% | 0.00 20.92% | 0.01 188.71% | 0.04 295.32% | |
debt to equity | -0.00 - | -0.00 55.62% | 0.00 575.10% | 0.00 24.75% | 0.01 198.30% | 0.04 299.92% | |
dividend yield | |||||||
earnings yield | -0.01 - | -0.07 512.07% | -0.33 382.58% | -0.02 95.30% | -0.07 368.09% | -0.10 33.98% | |
enterprise value | 18.51B - | 18.79B 1.53% | 4.80B 74.48% | 7.56B 57.61% | 4.39B 41.86% | 2.97B 32.45% | |
enterprise value over ebitda | -88.37 - | -14.08 84.07% | -2.11 84.98% | -20.35 862.60% | -12.32 39.50% | -7.91 35.74% | |
ev to operating cash flow | -426.97 - | -173.87 59.28% | -22.56 87.03% | -38.39 70.20% | -21.90 42.97% | ||
ev to sales | 98.91K - | 366.16 99.63% | 134.61 63.24% | 27.64 79.47% | 12.05 56.42% | ||
free cash flow per share | -0.08 - | -0.19 149.50% | -1.71 803.96% | -1.42 17.03% | -0.81 43.11% | ||
free cash flow yield | -0.00 - | -0.01 143.58% | -0.08 1,222.08% | -0.10 31.08% | -0.09 7.14% | ||
graham net net | -1.36 - | -3.67 170.49% | 6.41 274.81% | 2.54 60.32% | 1.75 31.06% | 1.23 29.83% | |
graham number | 3.40 - | 13.53 297.42% | 37.29 175.58% | 5.06 86.44% | 7.89 56.01% | 7.76 1.64% | |
income quality | 0.21 - | 0.08 60.61% | 0.09 15.10% | 0.76 706.69% | 0.50 34.11% | ||
intangibles to total assets | 0 - | 0.02 Infinity% | 0.08 300.18% | 0.21 174.76% | 0.30 41.67% | 0.35 15.44% | |
interest coverage | -9.89K - | -21.21K 114.46% | -38.52K 81.60% | -679.37 98.24% | -221.54 67.39% | ||
interest debt per share | 0.00 - | 0.00 16.89% | 0.02 949.89% | 0.02 19.59% | 0.05 155.63% | 0.20 293.61% | |
inventory turnover | 0.04 - | 0.57 1,375.11% | 3.85 575.56% | 2.32 39.57% | 3.14 35.10% | ||
invested capital | -0.00 - | -0.00 55.62% | 0.00 575.10% | 0.00 24.75% | 0.01 198.30% | 0.04 299.92% | |
market cap | 18.53B - | 18.98B 2.43% | 6.82B 64.06% | 8.67B 27.11% | 5.53B 36.18% | 3.90B 29.60% | |
net current asset value | -778.93M - | -2.10B 169.11% | 2.01B 195.71% | 1.61B 19.66% | 1.16B 28.02% | 854.60M 26.34% | |
net debt to ebitda | 0.12 - | 0.14 22.38% | 0.89 524.29% | 3.00 235.65% | 3.20 6.55% | 2.47 22.58% | |
net income per share | -0.36 - | -2.26 526.95% | -7.47 229.96% | -0.22 97.03% | -0.64 186.75% | -0.59 7.31% | |
operating cash flow per share | -0.08 - | -0.19 149.34% | -0.70 274.18% | -0.32 53.89% | -0.32 2.16% | ||
payables turnover | 0.00 - | 0.18 7,170.21% | 4.36 2,262.41% | 2.58 40.76% | 4.05 56.81% | ||
receivables turnover | 1.15 - | 2.52 119.94% | |||||
research and ddevelopement to revenue | 523.49 - | 13.71 97.38% | 3.01 78.04% | 1.16 61.49% | 0.50 56.67% | ||
return on tangible assets | -2.19 - | -1.03 53.09% | -0.94 8.53% | -0.05 94.54% | -0.19 268.54% | -0.18 5.95% | |
revenue per share | 0.00 - | 0.04 13,013.97% | 0.09 113.50% | 0.25 171.75% | 0.38 52.30% | ||
roe | 0.25 - | 0.63 148.87% | -0.90 243.36% | -0.04 95.19% | -0.15 237.81% | -0.13 11.21% | |
roic | 0.01 - | 0.64 4,353.44% | -0.90 241.69% | -0.06 92.91% | -0.14 122.02% | -0.13 6.69% | |
sales general and administrative to revenue | 38.09 - | 20.92 45.08% | 2.25 89.26% | 1.20 46.60% | 0.80 33.66% | ||
shareholders equity per share | -1.43 - | -3.60 151.92% | 8.28 330.17% | 5.12 38.14% | 4.35 15.12% | 4.54 4.39% | |
stock based compensation to revenue | 246.33 - | 22.42 90.90% | 3.35 85.05% | 1.38 58.92% | 0.57 58.79% | ||
tangible asset value | -777.30M - | -2.09B 169.33% | 2.30B 209.90% | 2.40B 4.24% | 1.83B 23.71% | 1.78B 2.72% | |
tangible book value per share | -1.35 - | -3.60 166.11% | 7.61 311.62% | 3.95 48.09% | 2.89 26.77% | 2.76 4.41% | |
working capital | 88.94M - | 1.22B 1,274.56% | 2.01B 64.53% | 1.62B 19.53% | 1.21B 25.40% | 890.35M 26.27% |
All numbers in HKD (except ratios and percentages)